Cat. #151447
CMT 64 Cell Line
Cat. #: 151447
Unit size: 1x10^6 cells / vial
Availability: 10-12 weeks
Organism: Mouse
Tissue: Lung
Disease: Cancer
Model: Tumour line
£575.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Peter Riddle
Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: CMT 64 Cell Line
- Alternate name: CMT-64; CMT.64; CMT 64; C57 Mouse Tumor 64
- Cancer: Lung cancer
- Cancers detailed: Lung carcinoma;Metastatic
- Research fields: Cancer;Drug development
- Organism: Mouse
- Tissue: Lung
- Disease: Cancer
- Growth properties: Tumorigenesis
- Model: Tumour line
- Description: The tumourigenic and metastatic CMT 64 murine cell line is an in vivo mouse tumourigenesis system to study the growth characteristics and metastasis of mouse tumour lines (homoplastic with stable CMT 167 line); it demonstrates stable growth characteristics and morphology in culture and in lung metastasis induced after subcutaneous inoculation of mice.
- Production details: Mouse; CMT 64 isolated from primary alveogenic lung carcinoma tumour mass in C57BL/lcrf mouse, achieving stable morphology and growth rate in culture, similar to growth rate and morphology in primary tumour, and in lung metastasis induced after subcutaneous innoculation of mice.
- Cellosaurus id: CVCL_2406
Handling
- Format: Frozen
- Growth medium: DMEM + 2mM Glutamine + 10% Foetal Bovine Serum (FBS).
- Unit size: 1x10^6 cells / vial
- Shipping conditions: Dry ice
- Subculture routine: Split sub-confluent cultures (70-80%) 1:4 to 1:10 seeding at approximately 3 x 10^4 cells/cm² using 0.05% trypsin or trypsin/EDTA; 5% CO₂; 37°C. Saturation density 1.2 x 10^5 cells/cm²
Related Tools
- Related tools: CMT 64/61 Cell Line ; CMT 170 Cell Line
References
- Rincn et al. 2017. Oncotarget. : PMID: 28525366.
- Franks et al. 1976. Cancer Res. 36(3):1049-1055. PMID: 1253168.
